← Leaderboards
Shashikant K Phadtare
Xavier University Of Louisiana
$1,714,970
Attributed
$1,714,970
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $181K · FY2005–11$200K$150K$100K$50K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$1,714,970 · 4
By mechanism
S06$796,234 · 1
SC1$716,485 · 1
R03$145,108 · 1
R24$57,143 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Drug Design /Synthesis /Production”
- Dennis L. Kasper · Harvard Medical School$26,605,444
- Myron Max Levine · University Of Maryland Baltimore$22,074,862
- George R Painter · Chimerix, Inc.$19,230,662
- Donald L Fine · Dynport Vaccine Company, Llc$9,996,228
- Dennis E. Hruby · Oregon State University$9,654,233
- William C Olson · Progenics Pharmaceuticals, Inc.$8,361,679
Research focus
Drug Design /Synthesis /ProductionDrug Screening /EvaluationPurineNeoplasm /Cancer ChemotherapyPharmacy FacilityPropertyEvaluationCollegeLouisianaNational Cancer InstitutePharmaceutical PreparationsAnticancer ActivityAntineoplastic AgentsChemotherapyBaseExhibitsAnalogCause Of DeathDesignIn VitroMalignant NeoplasmsModificationNucleic AcidsPurines
Grant awards (15)
Investigation of Nucleic Acid Based Derived Tamoxifen Analogues for Breast Cancer$181,002
SC1 · FY2011 · GM · contact PI
Investigation of Nucleic Acid Based Derived Tamoxifen Analogues for Breast Cancer$180,606
SC1 · FY2010 · GM · contact PI
Investigation of Nucleic Acid Based Derived Tamoxifen Analogues for Breast Cancer$178,467
SC1 · FY2009 · GM · contact PI
Investigation of Nucleic Acid Based Derived Tamoxifen Analogues for Breast Cancer$176,410
SC1 · FY2008 · GM · contact PI
Aromatic Neplanocin Analogues for Cancer Chemotherapy$160,367
S06 · FY2007 · GM · contact PI
Aromatic Neplanocin Analogues for Cancer Chemotherapy$95,736
S06 · FY2006 · GM · contact PI
Aromatic Neplanocin Analogues for Cancer Chemotherapy$93,021
S06 · FY2005 · GM
Aromatic Neplanocin Analogues for Cancer Chemotherapy$111,384
S06 · FY2004 · GM
NEW PHENYL NUCLEOSIDES AS ANTI-HIV AGENTS$72,554
R03 · FY2003 · DA
AMIFOSTINE ESTERS FOR CYTOTOXIC CHEMOPROTECTION$148,636
S06 · FY2002 · GM
NEW PHENYL NUCLEOSIDES AS ANTI-HIV AGENTS$72,554
R03 · FY2002 · DA
AMIFOSTINE ESTERS FOR CYTOTOXIC CHEMOPROTECTION$148,636
S06 · FY2001 · GM
AMIFOSTINE ESTERS FOR CYTOTOXIC CHEMOPROTECTION$38,454
S06 · FY2001 · GM
PHOSPHOANIONIC DELIVERY OF ANTIAIDS &DRUG ABUSE ANTAGONISTS$0
R24 · FY2001 · DA
PHOSPHOANIONIC DELIVERY OF ANTIAIDS &DRUG ABUSE ANTAGONISTS$57,143
R24 · FY2000 · DA